Type
. Primary involvement of the palms and soles in leprosy--report of two cases. Indian journal of leprosy. 1990;62(1):123-5.
Type
. Caution when standardizing serum antibody competition assays. Transactions of the Royal Society of Tropical Medicine and Hygiene. 1990;84(1):137-8.
Type
. Cross-reactive idiotypes in sera from patients with leprosy, lupus and Lyme disease and from healthy individuals. Clinical and experimental immunology [Internet]. 1990;79(1):78-82. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1534717/pdf/clinexpimmunol00076-0080.pdf
Type
. Effect of tuftsin stimulation on the microbicidal activity exerted by blood monocyte-macrophages of leprosy patients. International journal of immunopharmacology. 1990;12(8):859-69.
Type
. Modulation of human lepromatous monocyte-macrophage functions in vitro by tuftsin. International journal of immunopharmacology. 1990;12(8):847-58.
Type
. A time-dependent logistic hazard function for modeling variable age of onset in analysis of familial diseases. Genetic epidemiology. 1990;7(6):391-407.
Type
. [Polyarthritis in leprosy (author's transl)]. La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris. 1979;55(41-42):1889-92.
Type
. Serum angiotensin-converting enzyme, transcobalamin and lysozyme in normal and lepromatous armadillos. Journal of the Reticuloendothelial Society. 1979;26(4):367-72.
Type
. [Correlation between dyslipoproteinemia and coronary risk. Therapeutic effect of essential phospholipids on LDL/HDL]. Die Medizinische Welt. 1979;30(48):1827-32.
Type
. Immunotherapy for leprosy. Archives of dermatology. 1977;113(12):1731.